Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-I Env protein

被引:64
作者
Milich, L
Margolin, BH
Swanstrom, R [1 ]
机构
[1] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA
关键词
D O I
10.1006/viro.1997.8821
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The V3 domain plays a central role in the biology of the HIV-I Env glycoprotein gp120 as a dominant target for neutralizing antibodies for some HIV-1 isolates, and as a major determinant in the switch from the nonsyncytium-inducing (RIS) to the syncytium-inducing (SI) form of HIV-1 that is associated with accelerated disease progression. Basic amino acid substitutions are known to play an important role in the S1 phenotype. We have used the presence of basic amino acid substitutions in V3 sequences to divide sequences in a large data base into Si-like and NSI-like. We found significant differences in features of sequence variability between these two groups of sequences. Of the thirty-six most frequent substitutions in V3, twenty appear disproportionately among either the Si like sequences or the NSI-like sequences. The fourteen favored substitutions among the SI-like sequences account for 50% of the twofold increased variability seen in this group. In addition, we found a linked change within the CD4-binding domain of gp120 downstream of V3. These differences are interpreted in the context of structure, function, and selective pressure. An understanding of these patterns of sequence variability offers the possibility of designing a degenerate SI-specific V3 immunogen Po use as a therapeutic vaccine with the hope of slowing or preventing the appearance of SI variants, (C) 1997 Academic Press.
引用
收藏
页码:108 / 118
页数:11
相关论文
共 62 条
[1]  
ASJO B, 1986, LANCET, V2, P660
[2]   AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION [J].
BACK, NKT ;
SMIT, L ;
DEJONG, JJ ;
KEULEN, W ;
SCHUTTEN, M ;
GOUDSMIT, J ;
TERSMETTE, M .
VIROLOGY, 1994, 199 (02) :431-438
[3]   Covariability of V3 loop amino acids [J].
Bickel, PJ ;
Cosman, PC ;
Olshen, RA ;
Spector, PC ;
Rodrigo, AG ;
Mullins, JI .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (15) :1401-1411
[4]   CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION [J].
BOUHABIB, DC ;
RODERIQUEZ, G ;
ORAVECZ, T ;
BERMAN, PW ;
LUSSO, P ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6006-6013
[5]   A SINGLE AMINO-ACID SUBSTITUTION IN THE V1 LOOP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 ALTERS CELLULAR TROPISM [J].
BOYD, MT ;
SIMPSON, GR ;
CANN, AJ ;
JOHNSON, MA ;
WEISS, RA .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3649-3652
[6]   Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: Role of the V3 loop and C4 envelope determinants [J].
Carrillo, A ;
Ratner, L .
JOURNAL OF VIROLOGY, 1996, 70 (02) :1301-1309
[7]   IDENTIFICATION OF HIV-1 DETERMINANTS FOR T-LYMPHOID CELL-LINE INFECTION [J].
CARRILLO, A ;
TROWBRIDGE, DB ;
WESTERVELT, P ;
RATNER, L .
VIROLOGY, 1993, 197 (02) :817-824
[8]   BIOLOGIC FEATURES OF HIV-1 THAT CORRELATE WITH VIRULENCE IN THE HOST [J].
CHENGMAYER, C ;
SETO, D ;
TATENO, M ;
LEVY, JA .
SCIENCE, 1988, 240 (4848) :80-82
[9]  
CHENGMAYER C, 1988, P NATL ACAD SCI USA, V85, P1815
[10]   MACROPHAGE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES FROM DIFFERENT PATIENTS EXHIBIT UNUSUAL V3 ENVELOPE SEQUENCE HOMOGENEITY IN COMPARISON WITH T-CELL-TROPIC ISOLATES - DEFINITION OF CRITICAL AMINO-ACIDS INVOLVED IN CELL TROPISM [J].
CHESEBRO, B ;
WEHRLY, K ;
NISHIO, J ;
PERRYMAN, S .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6547-6554